Firefly Neuroscience (AIFF) Balance Sheet: Assets & Liabilities

Firefly Neuroscience (AIFF) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Firefly Neuroscience reported total assets of $10.48M and total liabilities of $2.84M. Shareholders' equity was $7.64M. Total debt stood at $0.00 against $2.75M in cash and short-term investments, a net cash position of $2.75M. That puts debt-to-equity at 0.00.

Firefly Neuroscience Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Firefly Neuroscience, Inc. (AIFF) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	2.75	1.81	2.14	0.06	0.65	1.86
Cash & Short-Term Investments	2.75	1.81	2.14	0.06	0.65	1.86
Accounts Receivable	0.19	0.12	0.08	1.63	0.04	1.44
Inventory	0.11	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.98	0.70	0.03	0.44	0.28	0.05
Total Current Assets	4.03	2.63	2.26	0.08	0.70	3.35
Non-Current Assets
Property, Plant & Equipment (Net)	0.15	0.14	0.00	0.48	0.19	0.11
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.21
Goodwill	5.18	0.00	0.00	1.13	7.59	0.00
Intangible Assets	0.21	0.18	0.39	1.18	0.00	0.00
Other Non-Current Assets	0.27	1.66	0.00	2.40	0.08	0.10
Total Non-Current Assets	6.45	1.97	0.39	0.05	0.25	0.42
Total Assets	10.48	4.60	2.64	0.14	0.95	3.77
Current Liabilities
Accounts Payable	1.35	1.82	0.63	0.57	0.50	0.10
Short-Term Debt	0.00	0.69	0.00	0.43	1.79	0.14
Accrued Liabilities	0.77	1.63	1.90	1.09	0.75	-
Deferred Revenue	0.23	0.01	0.00	0.18	0.46	0.95
Other Current Liabilities	0.48	2.45	1.90	1.42	1.22	0.61
Total Current Liabilities	2.82	4.98	2.53	3.89	3.97	1.80
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.36
Other Non-Current Liabilities	0.02	0.00	0.00	0.06	3.43	0.00
Total Non-Current Liabilities	0.02	0.00	0.00	0.36	3.94	0.36
Total Liabilities	2.84	4.98	2.53	2.36	3.97	2.16
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.02	0.13
Retained Earnings	-111.62	-87.08	-76.62	-31.19	-67.33	-12.31
Additional Paid-in Capital	119.25	86.71	76.73	71.78	61.89	13.79
Shares Outstanding	13.96	8.12	8.12	7.87	7.87	-
Total Stockholders' Equity	7.64	-0.38	0.11	-2.23	-3.01	1.61
Total Liabilities & Equity	10.48	4.60	2.64	0.14	0.95	3.77

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Firefly Neuroscience Balance Sheet

How much debt does Firefly Neuroscience have?

Firefly Neuroscience had total debt of $0.00 as of Dec 31, 2025, against $2.75M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $694.00K a year earlier.

What are Firefly Neuroscience's total assets?

Firefly Neuroscience reported total assets of $10.48M as of Dec 31, 2025, up 127.7% from $4.60M a year earlier. Total liabilities were $2.84M.

What is Firefly Neuroscience's shareholders' equity?

Firefly Neuroscience's shareholders' equity was $7.64M as of Dec 31, 2025, or about $0.55 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition